The team developed a working prototype of the reader that can read a microsensor that is 0.9 millimeters in diameter while implanted underneath the skin using a syringe.

In lab experiments, the reader was able to monitor the rate of breathing and heart rate by detecting subtle movements of the battery-free microsensor. It took two years of research by the team, from ...

Microtech has commenced human clinical trials of its implantable microsensor platform, aimed at measuring atrial pressures critical in managing heart failure. Prof Erez Sharoni of Beilinson ...

Microtech implantable microsensor platform is the culmination of decades of development in a new class of sensor technology that can be used not only as a stand-alone device but can also be ...

TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human ...

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical ...

Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology. Share.

The microsensor effort began as a partnership between the Center and ROK ADD in 2018 to successfully meet the stringent form-factor requirements set forth by the customer.

Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a ...